Milestone Scientific Inc. (MLSS)

[Adrock]

News out

Milestone Scientific’s Epidural & Intra-Articular Subsidiary Submits Initial Results of Clinical Trial to Premier Pain Management Society for Publication

LIVINGSTON, NJ, October 22, 2015 -- Milestone Scientific Inc.’s (NYSE: MLSS) Epidural & Intra-Articular (IA) Subsidiary today announced that it has submitted an abstract to a prestigious American pain management society in advance of their annual meeting in 2016 detailing initial results of the Company’s prospective, open labeled, clinical trial assessing the CompuFlo® technology in correctly identifying the epidural space during an epidural procedure.

Milestone’s Epidural & Intra-Articular (IA) Subsidiary designed the study, in conjunction with its Scientific Advisory Board, and in agreement with the U.S. Food and Drug Administration (FDA), to assess safety and effectiveness of the pressure sensing technology in identification of the epidural space.

Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "We are pleased to submit the initial results of this clinical trial and look forward to fully disclosing the data at this prestigious organization’s annual meeting early next year.”